Работы, цитирующие эту работу

Работ: 4

Работа: An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis

1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Обзорная статьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2017Цитирований: 4

   ABIABI:AkademIndex/openalex/2017.review-article.000004

2. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 2

   ABIABI:AkademIndex/openalex/2021.article.000207

3. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2019.article.000020

4. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

   Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

   СтатьяTuberculosis Research and EpidemiologyERJ Open Research2020Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.360284